Preserving Geriatric Muscle With an Osteoporosis Medication - Trial NCT06118905
Access comprehensive clinical trial information for NCT06118905 through Pure Global AI's free database. This Phase 4 trial is sponsored by Susan L. Greenspan and is currently Not yet recruiting. The study focuses on Osteoporosis. Target enrollment is 248 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Susan L. Greenspan
University of Pittsburgh
Timeline & Enrollment
Phase 4
Jan 01, 2024
Apr 01, 2028
Primary Outcome
Knee extension strength change
Summary
Our goal is to demonstrate efficacy of the novel agent Denosumab to improve or preserve
 muscle health, strength, mobility and function in frail older adults.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06118905
Non-Device Trial